Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
The objective was to determine the concentrations of biomarkers of fibrosis and inflammation in the blood, parameters characterizing heart remodeling in patients with atrial fibrillation (AF) in combination with type 2 diabetes mellitus (T2DM).Methods and materials. The study included 231 examined p...
Saved in:
| Main Authors: | V. A. Ionin, E. I. Barashkova, A. M. Ananev, V. A. Pavlova, E. L. Zaslavskaya, E. I. Baranova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Academician I.P. Pavlov First St. Petersburg State Medical University
2022-11-01
|
| Series: | Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова |
| Subjects: | |
| Online Access: | https://www.sci-notes.ru/jour/article/view/913 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation
by: V. A. Ionin, et al.
Published: (2022-09-01) -
Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01) -
Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome
by: E. I. Barashkova, et al.
Published: (2024-06-01) -
Nocturnal hypoxemia, cardiac remodeling, and blood concentrations of fibrosis biomarkers in patients with atrial fibrillation and obstructive sleep apnea
by: V. A. Berdysheva, et al.
Published: (2025-01-01) -
ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)